Networkers at heart

We would like to shape Life Science’s future – out of Northern Germany

About us
Nach unten

Minister Madsen visits European XFEL

Schleswig-Holstein's Minister of Economic Affairs, Transport, Employment, Technology and Tourism Claus Ruhe Madsen visited European XFEL yesterday. Mr Madsen familiarized himself with the fields of ...

Read more …
Bastian Rouven Brückner, Head of Operations, Merck Group/AmpTec GmbH, Peter Scheinert, Founder & CEO, AmpTec GmbH, Prof. Simone Spuler, Head of the Myology Lab at the Experimental and Clinical Research Center (ECRC), Dr. Matthias Jöhnck, Senior Director m
Bastian Rouven Brückner, Head of Operations, Merck Group/AmpTec GmbH, Peter Scheinert, Founder & CEO, AmpTec GmbH, Prof. Simone Spuler, Head of the Myology Lab at the Experimental and Clinical Research Center (ECRC), Dr. Matthias Jöhnck, Senior Director mRNA Value Chain, Synthesis & ADC, Merck Life Science Services and MD AmpTec GmbH and Tanja Stadie, Head Of Quality, Merck Group/AmpTec GmbH at the official opening of the new mRNA production facility in Hamburg. (from left - Image: Merck KGaA)

Merck/AmpTec: New mRNA manufacturing site opened in Hamburg

Merck, a leading science and technology company, today became the first CTDMO (contract testing, development and manufacturing organization) to offer integrated services for all critical ...

Read more …
Since many years Birn + Partners is a reliable renowned life science company and today represented in ten countries.
Since many years Birn + Partners is a reliable renowned life science company and today represented in ten countries. (Image: totojang1977|stock.adobe.com / Birn + Partners)

A new member of LSN e.V.: Birn + Partners

Founded in 2013 by Mikkel F. Birn in Denmark, the executive search company is now represented by over 60 consultants and partners in ten countries. ...

Read more …

Cellbox Solutions Awarded €2.5 Million Grant

Cellbox Solutions GmbH, a leading provider of warm chain logistics solutions for the research, development and shipment of cell-based therapies and cellular diagnostics, today announced ...

Read more …

IDERHA consortium takes off

The newly formed IDERHA consortium, consisting of academia, industry, health authorities, clinicians, and patient representatives, addresses the obstacles in accessing, integrating and analysing health data ...

Read more …

tiakis: Treatment of COVID-19

tiakis Biotech AG announced today that a first patient has been dosed in the COMCOVID trial, a Phase Ib/II trial evaluating the Company’s key investigational ...

Read more …